Baxter International Inc

Healthcare · Medical Instruments & Supplies

22.90$ +0.6% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Income Statement

Baxter International Inc (BAX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 11,244 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement BAX
Line item	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	5,438	5,259	5,706	6,380	6,697	7,356	8,099	8,916	9,509	9,849	10,378	11,263	12,348	12,562	12,843	13,893	13,936	9,413	10,719	9,968	10,163	10,584	11,099	11,362	11,673	12,146	10,057	10,360	10,636	11,244
Cost of Revenue	2,697	2,570	2,816	3,215	3,641	3,944	4,314	4,951	5,594	5,756	5,641	5,744	6,218	6,037	6,885	6,847	6,802	5,251	6,138	5,822	6,047	6,110	6,340	6,601	7,086	7,426	6,508	6,210	6,652	7,865
Gross Profit	2,741	2,689	2,890	3,165	3,056	3,412	3,785	3,965	3,915	4,093	4,737	5,519	6,130	6,525	5,958	7,046	7,134	4,162	4,581	4,146	4,116	4,474	4,759	4,761	4,587	4,720	3,549	4,150	3,984	3,379
Research & Development	340	339	323	332	378	426	501	553	517	533	614	760	868	917	915	946	1,081	582	610	603	646	615	654	595	521	531	450	518	590	518
Selling, General & Administrative	1,142	1,356	1,426	1,311	1,385	1,469	1,562	1,796	2,249	2,030	2,282	2,521	2,698	2,731	2,907	3,924	3,324	3,681	4,029	3,094	21	2,627	2,620	2,535	2,469	2,845	3,097	3,938	2,967	2,890
Total Operating Expenses	1,830	1,802	1,875	2,015	2,022	2,189	2,256	2,349	3,020	2,454	2,896	3,351	3,566	3,648	3,822	4,100	4,313	3,666	3,925	3,697	3,371	3,186	3,175	2,989	2,971	3,370	6,394	3,443	3,970	3,687
Operating Income	911	887	1,015	1,150	1,034	1,223	1,529	1,279	895	1,639	1,841	2,168	2,564	2,877	2,136	2,946	2,821	496	656	449	745	1,288	1,584	1,772	1,616	1,350	-2,845	707	14	-308
Interest Expense	214	0.0	193	0.0	131	108	71	115	99	118	101	124	148	117	115	54	113	155	167	146	89	85	93	111	153	207	413	508	408	290
Pre-Tax Income	793	570	493	1,052	962	979	1,386	1,150	430	1,444	1,746	2,114	2,462	2,734	1,890	2,809	2,838	375	490	428	4,954	1,100	1,617	970	1,292	1,116	-3,248	242	-289	-505
Income Tax Expense	218	199	218	273	208	304	360	228	47	486	348	407	437	519	463	553	555	60	33	35	-12	491	65	-41	182	83	-135	61	37	395
Net Income	669	300	315	797	740	612	771	881	388	956	1,396	1,707	2,014	2,205	1,420	2,224	2,326	2,012	2,497	968	4,965	602	1,546	1,001	1,102	1,284	-2,433	2,656	-649	-957
EBITDA	1,259	1,205	1,359	1,522	1,714	1,930	2,157	2,540	2,039	2,110	2,416	2,819	3,241	3,489	2,690	3,616	3,663	1,165	1,449	1,333	5,843	1,935	2,481	1,870	2,268	2,190	-1,763	1,734	1,116	766

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings